Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rapamycin: brain excitability studied in vitro.

Delchad Daoud1, Hans H Scheld, Erwin-Josef Speckmann

  • 1Institut für Physiologie I, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Epilepsia
|February 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Attacks on medical facilities during war demand global response.

BMJ (Clinical research ed.)·2026
Same author

Protocol Optimization for Exosome Production From Umbilical Cord Mesenchymal Stem Cells: A Step Toward Clinical Translation.

Basic and clinical neuroscience·2026
Same author

The Impact of Small Molecule on the Astrocyte's Viability Derived From Epileptic Brain Tissues.

Basic and clinical neuroscience·2026
Same author

Dysregulated Notch1 signaling in seizures: Insights from a genetic model of absence epilepsy.

Epilepsy research·2026
Same author

Apoptosis and Glial Marker Profiles in Hippocampus and Amygdala of Medically Intractable Temporal Lobe Epilepsy.

Journal of cellular and molecular medicine·2026
Same author

Integrating social and neurobehavioral understandings of epilepsy stigma into personalized care strategies.

Epilepsy & behavior : E&B·2026
Same journal

Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

Epilepsia·2026
Same journal

Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

Epilepsia·2026
Same journal

Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

Epilepsia·2026
Same journal

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same journal

Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

Epilepsia·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
See all related articles

Rapamycin, an alternative immunosuppressant, did not cause neurotoxicity like calcineurin inhibitors. This study found rapamycin safe for transplant patients, unlike FK506, which induced seizures and altered brain activity.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Transplantation Medicine

Background:

  • Calcineurin inhibitors (e.g., FK506) are crucial immunosuppressants post-transplant.
  • Neurotoxicity, including seizures, is a significant side effect of calcineurin inhibitors.
  • Rapamycin is explored as a safer alternative due to potential neurotoxic effects of calcineurin inhibitors.

Purpose of the Study:

  • To investigate the neurophysiological effects of rapamycin.
  • To compare rapamycin's effects with FK506 on hippocampal bioelectrical activity.
  • To evaluate rapamycin as a potential alternative for calcineurin inhibitor-induced neurotoxicity.

Main Methods:

  • Electrophysiological recordings in rat hippocampal CA1 area.
  • Assessment of spontaneous bioelectrical activity.

Related Experiment Videos

  • Measurement of evoked field excitatory postsynaptic potentials (fEPSP) magnitude.
  • Comparative analysis of rapamycin and FK506.

    • Main Results:

    • Rapamycin, at tested concentrations, did not alter hippocampal bioelectrical activity.
    • Rapamycin did not significantly affect fEPSP magnitude in CA1.
    • FK506 induced epileptiform burst discharges and enhanced fEPSP magnitude.
    • FK506 demonstrated significant neuroexcitatory effects.

    Conclusions:

    • Rapamycin exhibits a neuroprotective profile, lacking the epileptogenic effects of FK506.
    • Rapamycin represents a viable alternative immunosuppressant for patients experiencing calcineurin inhibitor-associated neurotoxicity.
    • Further clinical studies are warranted to confirm rapamycin's safety and efficacy in transplant recipients.